Total Funding
85
65
Total FundingPost-IPO Equity raised
Growth Score
-11 pts
Heat Score
10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
36274
Spyre Therapeutics is a biotechnology business that is developing a strong pipeline of antibody therapies.
Acquired by 
Aeglea BioTherapeutics
- Scott Burrows: Chief Financial Officer
- Cameron Turtle: Chief Executive OfficerPast Role: BridgeBio, Chief Strategy Officer
About the Company
Spyre Therapeutics is a biotechnology business that is developing a strong pipeline of antibody therapies with the potential to revolutionize the treatment of inflammatory bowel disease (IBD).
